Indications

Metabolic Disease

  • 50+ clinical sites in Poland, Bulgaria
  • 50+ investigators in endocrinology

Osteoporosis

  • phase II trial in 160 female patients with bone density measurement
  • phase III trial in 450 female patients

Hypercholesterolemia

  • phase III trials in 120 patients
  • seven phase III trials in over 2200 type 1 and type 2 diabetes patients